Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Chosa Oncology AB

Closing information (x1000 EUR)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 24 More Arrow 49 More Arrow 133
Earnings before taxes -835 Less Arrow -2,141 Less Arrow -3,694
EBITDA -786 Less Arrow -2,050 Less Arrow -3,695
Total assets 1,444 More Arrow 1,751 More Arrow 2,506
Current assets 612 More Arrow 858 More Arrow 2,506
Current liabilities 241 Less Arrow 182 More Arrow 1,693
Equity capital 1,203 More Arrow 1,569 Less Arrow 813
- share capital 1,112 Less Arrow 1,052 Less Arrow 308
Employees (average) 1 Equal arrow 1 More Arrow 4

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 83.3% More Arrow 89.6% Less Arrow 32.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -56.2% Less Arrow -119.5% Less Arrow -142.1%
Current ratio 253.9% More Arrow 471.4% Less Arrow 148.0%
Return on equity (ROE) -69.4% Less Arrow -136.5% Less Arrow -454.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Less Arrow -3 More Arrow 0
Chg. No. of employees % 0% Less Arrow -75% More Arrow 0%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.